Alteogen Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
601 / 1361
Position in country
2023 / 2780
Return on Assets, %
-1.5
-40.3
Net income margin, %
-59.8
-180
EBITDA margin, %
-32.2
-168.2
Debt to Equity, %
56.5
3.2
Intangible assets and goodwill, %
34.8
0.2
Revenue CAGR 3Y, %
31.5
12.5
Total Equity change 1Y, %
-3.1
-9
Revenue Y, % chg
227.9
0
P/BV
63.9
1.8
P/S
98.1
10.3
EV/S
97.8
7.5
EV/EBITDA
-816.3
-1.6
Average Analyst recommendation
Buy
Buy
Expected dividend per share
0
0
Competitors
Ranks
-
PharmaResearch Co Ltd
00%
-
Hugel Inc
00%
-
Amgen Inc
00%
-
Celltrion Inc
00%
-
Seegene Inc
00%
-
Alteogen Inc
00%
-
GC Biopharma Corp
00%
-
ABL Bio Inc
00%
-
AbbVie Inc
00%
-
SK Bioscience Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Korea; Republic (S. Korea)
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Sub-sector
Health Care
Capitalization (millions of $)
6929.8
Ticker
196170.KQ
ISIN
KR7196170005
IPO date
2014-12-12
Availability on Russian exchanges
No
Reporting for
2024-03-18
Date fact. publication of reports
2023-12-31
Company Description
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: